Author:
Brachem Christian,Weinhold Leonie,Alexy Ute,Schmid Matthias,Oluwagbemigun Kolade,Nöthlings Ute
Abstract
AbstractMetabolomics-derived metabolites (henceforth metabolites) may mediate the relationship between modifiable risk factors and clinical biomarkers of metabolic health (henceforth clinical biomarkers). We set out to study the associations of metabolites with clinical biomarkers and a potential mediation effect in a population of young adults. First, we conducted a systematic literature review searching for metabolites associated with 11 clinical biomarkers (inflammation markers, glucose, blood pressure or blood lipids). Second, we replicated the identified associations in a study population of n = 218 (88 males and 130 females, average age of 18 years) participants of the DONALD Study. Sex-stratified linear regression models adjusted for age and BMI and corrected for multiple testing were calculated. Third, we investigated our previously reported metabolites associated with anthropometric and dietary factors mediators in sex-stratified causal mediation analysis. For all steps, both urine and blood metabolites were considered. We found 41 metabolites in the literature associated with clinical biomarkers meeting our inclusion criteria. We were able to replicate an inverse association of betaine with CRP in women, between body mass index and C-reactive protein (CRP) and between body fat and leptin. There was no evidence of mediation by lifestyle-related metabolites after correction for multiple testing. We were only able to partially replicate previous findings in our age group and did not find evidence of mediation. The complex interactions between lifestyle factors, the metabolome, and clinical biomarkers warrant further investigation.
Funder
Bundesministerium für Bildung und Forschung
Rheinische Friedrich-Wilhelms-Universität Bonn
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table (Institute for Health Metrics and Evaluation (IHME), 2021).
2. Mozaffarian, D. et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 131, e29-322 (2015).
3. Zhang, A., Sun, H., Yan, G., Wang, P. & Wang, X. Metabolomics for biomarker discovery: moving to the clinic. Biomed Res. Int. 2015, 354671 (2015).
4. Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832 (2019).
5. López-López, Á., López-Gonzálvez, Á., Barker-Tejeda, T. C. & Barbas, C. A review of validated biomarkers obtained through metabolomics. Expert Rev. Mol. Diagn. 18, 557–575 (2018).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献